Differentiating Serine and Cysteine Protease Mechanisms by New Covalent QSAR Descriptors

Overview

Journal Chembiochem

Specialty Biochemistry

Date 2011 Mar 26

PMID 21438106

Citations 8

Authors

Michael Shokhen

Tamar Traube

Subramaniam Vijayakumar

Michal Hirsch

Neta Uritsky

Amnon Albeck

Affiliations

Soon will be listed here.

Citing Articles

Reactivities of acrylamide warheads toward cysteine targets: a QM/ML approach to covalent inhibitor design.

Danilack A, Dickson C, Soylu C, Fortunato M, Rodde S, Munkler H J Comput Aided Mol Des. 2024; 38(1):21.

PMID: 38693331 DOI: 10.1007/s10822-024-00560-6.

Exploring the Versatility of the Covalent Thiol-Alkyne Reaction with Substituted Propargyl Warheads: A Deciding Role for the Cysteine Protease.

Mons E, Kim R, van Doodewaerd B, Van Veelen P, Mulder M, Ovaa H J Am Chem Soc. 2021; 143(17):6423-6433.

PMID: 33885283 PMC: 8154518. DOI: 10.1021/jacs.0c10513.

Structural and Antiviral Studies of the Human Norovirus GII.4 Protease.

Muzzarelli K, Kuiper B, Spellmon N, Brunzelle J, Hackett J, Amblard F Biochemistry. 2019; 58(7):900-907.

PMID: 30605321 PMC: 7717172. DOI: 10.1021/acs.biochem.8b01063.

Characterization and functional assay of apsup (Lyxy105) from Lymantria xylina multiple nucleopolyhedrovirus (LyxyMNPV).

Chang J, Chang Z, Huang Y, Lee S, Kim J, Nai Y Virus Genes. 2018; 54(4):578-586.

PMID: 29876768 DOI: 10.1007/s11262-018-1580-1.

Cysteine protease inhibition by nitrile-based inhibitors: a computational study.

Quesne M, Ward R, de Visser S Front Chem. 2014; 1:39.

PMID: 24790966 PMC: 3982517. DOI: 10.3389/fchem.2013.00039.

References

Tavares F, Boncek V, Deaton D, Hassell A, Long S, Miller A . Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k. J Med Chem. 2004; 47(3):588-99. DOI: 10.1021/jm030373l. View

Bachand B, Tarazi M, St-Denis Y, Edmunds J, Winocour P, Leblond L . Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors. Bioorg Med Chem Lett. 2001; 11(3):287-90. DOI: 10.1016/s0960-894x(00)00636-3. View

Shokhen M, Khazanov N, Albeck A . The mechanism of papain inhibition by peptidyl aldehydes. Proteins. 2010; 79(3):975-85. DOI: 10.1002/prot.22939. View

Maryanoff B, Costanzo M . Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2007; 16(4):1562-95. DOI: 10.1016/j.bmc.2007.11.015. View

Shokhen M, Albeck A . Factors determining the relative stability of anionic tetrahedral complexes in serine protease catalysis and inhibition. Proteins. 2000; 40(1):154-67. DOI: 10.1002/(sici)1097-0134(20000701)40:1<154::aid-prot170>3.0.co;2-v. View

Christianson D, Lipscomb W . Structure of the complex between an unexpectedly hydrolyzed phosphonamidate inhibitor and carboxypeptidase A. J Am Chem Soc. 2011; 108(3):545-6. DOI: 10.1021/ja00263a052. View

Frankfater A, Kuppy T . Mechanism of association of N-acetyl-L-phenylalanylglycinal to papain. Biochemistry. 1981; 20(19):5517-24. DOI: 10.1021/bi00522a026. View

Shokhen M, Khazanov N, Albeck A . Enzyme isoselective inhibitors: application to drug design. ChemMedChem. 2006; 1(6):639-43. DOI: 10.1002/cmdc.200600030. View

Otto H, Schirmeister T . Cysteine Proteases and Their Inhibitors. Chem Rev. 1997; 97(1):133-172. DOI: 10.1021/cr950025u. View

10.

Shokhen M, Khazanov N, Albeck A . Challenging a paradigm: theoretical calculations of the protonation state of the Cys25-His159 catalytic diad in free papain. Proteins. 2009; 77(4):916-26. PMC: 2767454. DOI: 10.1002/prot.22516. View

11.

Costanzo M, Almond Jr H, Hecker L, Schott M, Yabut S, Zhang H . In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design. J Med Chem. 2005; 48(6):1984-2008. DOI: 10.1021/jm0303857. View

12.

Hedstrom L . Serine protease mechanism and specificity. Chem Rev. 2002; 102(12):4501-24. DOI: 10.1021/cr000033x. View

13.

Ozeri R, Khazanov N, Perlman N, Shokhen M, Albeck A . Enzyme isoselective inhibitors: a tool for binding-trend analysis. ChemMedChem. 2006; 1(6):631-8. DOI: 10.1002/cmdc.200600029. View

14.

Jin B, Hopfinger A . A proposed common spatial pharmacophore and the corresponding active conformations of some TxA2 receptor antagonists. J Chem Inf Comput Sci. 1994; 34(4):1014-21. DOI: 10.1021/ci00020a041. View